BREAKING NEWS: New drug approved by the FDA for Duchenne muscular dystrophy. Learn more about this new treatment option.

Innovations in Care

We provide access to support and programs that empower the lives of people living with neuromuscular diseases.

MDA Engage Community Education Seminar: Kansas

Saturday, November 16, 2019MDA Engage Logo
Registration: 9:00am - 10:00am
Event: 10:00am - 4:00pm (lunch included)
Social Hour: 4:00pm - 5:00pm

Event Chair: Dr. Jeffrey Statland, Director, MDA Care Center, University of Kansas Medical Center

Event Location:
DoubleTree by Hilton Hotel Kansas City - Overland Park
10100 College Blvd
Overland Park, KS 66210

There is no cost to attend the event, however, registration is required.

Registration has Closed

  • Keynote Presentation- Advances in NMD Medicine
    • Jeffrey Statland, MD – University of Kansas
  • Research and Clinical Trial Review
    • Jeffrey Statland, MD – University of Kansas Medical Center
    • Michaela Walker – University of Kansas
  • Becoming your Own Advocate/ Peds to Adult Transition
    • Kathy Davis, PhD – University of Kansas
  • Genetic Testing
    • Raghav Govindarajan, MD – University of Missouri
  • Best Practices in Clinical Care
    • Constantine Farmakidis, MD – University of Kansas

 

Thank you to our supporters:

  • Sanofi Genzyme
  • AveXis
  • Genentech

For questions reach out to: mdaengage@mdausa.org | 1-833-ASK-MDA1 (1-833-275-6321)